{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Co-immunoprecipitation and in vitro pulldown assays confirm a direct interaction between ATXN3 and YAP, where ATXN3 deubiquitinates and stabilizes YAP.",
  "functions": [
    {
      "function": "YAP Protein Stabilization",
      "arrow": "activates",
      "cellular_process": "Yes-associated protein (YAP) is a transcriptional co-activator and the primary downstream effector of the Hippo signaling pathway. Its activity is tightly controlled by its stability, which is negatively regulated by the ubiquitin-proteasome system. Polyubiquitination, particularly with K48-linked chains, targets YAP for degradation, thus suppressing its pro-proliferative and anti-apoptotic functions.",
      "effect_description": "ATXN3 functions as a bona fide deubiquitinase (DUB) for YAP. It directly interacts with YAP and removes K48-linked polyubiquitin chains, thereby protecting YAP from proteasomal degradation. This stabilization increases YAP protein abundance, leading to its accumulation and enhanced transcriptional co-activator function in the nucleus.",
      "biological_consequence": [
        "ATXN3 directly binds to the WW domains of YAP → ATXN3's deubiquitinase activity removes K48-linked polyubiquitin chains from YAP → Prevention of YAP recognition by the proteasome → Increased YAP protein half-life and stability → Enhanced nuclear localization and accumulation of YAP → Increased formation of YAP/TEAD transcriptional complexes → Upregulation of target genes (e.g., CTGF, CYR61) → Promotion of cell proliferation, migration, and tumor growth."
      ],
      "specific_effects": [
        "ATXN3 directly interacts with, deubiquitinates, and stabilizes YAP in a manner dependent on its deubiquitinase activity.",
        "ATXN3 specifically removes K48-linked polyubiquitin chains from YAP, protecting it from degradation.",
        "Depletion of ATXN3 leads to decreased YAP protein levels and reduced expression of YAP target genes, such as CTGF and CYR61.",
        "The interaction is mediated by ATXN3 binding to the WW domains of YAP."
      ],
      "evidence": [
        {
          "paper_title": "ATXN3 promotes prostate cancer progression by stabilizing YAP",
          "journal": "Cell Communication and Signaling",
          "year": 2023,
          "relevant_quote": "Our results suggested that ATXN3 promotes prostate cancer progression by regulating YAP. As shown in Fig. 6A-G, reconstitution of YAP efficiently rescued the suppressive effects induced by ATXN3 depletion.",
          "pmid": "37349820"
        }
      ],
      "pathway": {
        "name": "Hippo Signaling Pathway",
        "canonical_name": "Hippo Signaling",
        "ontology_id": "hsa04390",
        "ontology_source": "KEGG",
        "confidence": 0.8
      },
      "pmids": [
        "37349820"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "main_to_primary",
      "function_effect": "activation"
    }
  ],
  "arrow": "activates",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "Yes-associated protein (YAP) is a transcriptional co-activator and the primary downstream effector of the Hippo signaling pathway. Its activity is tightly controlled by its stability, which is negatively regulated by the ubiquitin-proteasome system. Polyubiquitination, particularly with K48-linked chains, targets YAP for degradation, thus suppressing its pro-proliferative and anti-apoptotic functions.",
  "effect": "ATXN3 functions as a bona fide deubiquitinase (DUB) for YAP. It directly interacts with YAP and removes K48-linked polyubiquitin chains, thereby protecting YAP from proteasomal degradation. This stabilization increases YAP protein abundance, leading to its accumulation and enhanced transcriptional co-activator function in the nucleus.",
  "summary": "ATXN3 activates YAP to modulate yap protein stabilization, ultimately affecting promotion of cell proliferation, migration, and tumor growth.",
  "evidence": [
    {
      "paper_title": "ATXN3 deubiquitinates YAP1 to promote tumor growth and metastasis in breast cancer",
      "journal": "American Journal of Cancer Research",
      "year": 2023,
      "relevant_quote": "At the molecular level, ATNX3 interacts with the WW domains of YAP1 to protect YAP1 from ubiquitination-mediated degradation. Immunohistology analysis revealed a strong positive correlation between ATXN3 and YAP1 protein expression in human breast and pancreatic cancers. Collectively, our study defines ATXN3 as a previously unknown YAP1 deubiquitinase in tumorigenesis..."
    },
    {
      "paper_title": "ATXN3 promotes prostate cancer progression by stabilizing YAP",
      "journal": "Cell Communication and Signaling",
      "year": 2023,
      "relevant_quote": "Our results suggested that ATXN3 promotes prostate cancer progression by regulating YAP. As shown in Fig. 6A-G, reconstitution of YAP efficiently rescued the suppressive effects induced by ATXN3 depletion."
    }
  ],
  "pathways": [
    {
      "name": "Hippo Signaling Pathway",
      "canonical_name": "Hippo Signaling",
      "ontology_id": "hsa04390",
      "ontology_source": "KEGG",
      "confidence": 0.8
    }
  ],
  "interaction_effect": "activation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 1
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --activates--> YAP:",
  "protein_a": "YAP",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-01T05:51:49.732669Z",
  "last_updated": "2025-12-01T05:51:49.732669Z"
}